2018 Gamma Knife/Neuro Oncology Tumor Board (Occurs Weekly, Every Friday)

2018 Gamma Knife/Neuro Oncology Tumor Board (Occurs Weekly, Every Friday) Banner


Date & Location
Occurs weekly every Friday starting on 1/5/2018 at 7:00 AM, FHCI Orlando - Conference Room, Suite 182, Orlando, FL

Target Audience
Ear, Nose, And Throat

Overview
Multidisciplinary Team of Physicians discuss the latest staging, NCCN and study materials as applicable for each patient presented. The Physicians are fully engaged in finding the best treatment available for favorable outcomes.

Objectives

At the end of this course, participants should be able to:
  1. Utilize a Multidisciplinary, Case-Based Approach to discuss recent treatment guidelines to improve care for various cancer patients.
  2. Evaluate current clinical trials underway so that appropiate cancer patients may be considered for enrollment in those trials.
  3. Share lessons learned in treatment of difficult cases in order to provide alternative therapies and/or develop new protocols for management of cancer patients.
  4. Review site specific NCCN/ Gamma/Neuro Oncology Guidelines as appropiate per case.

Registration

COST: Complimentary

Occurs Every Friday Each Month -  7:00 AM to 8:30 AM



Accreditation

Florida Hospital is accredited by the Florida Medical Association (FMA) to provide continuing medical education for physicians. Florida Hospital designates this educational activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™

Physicians should only claim the credit commensurate with the extent of their participation in the activity.


Location:

Florida Hospital Cancer Institute
2501 N. Orange Avenue | Orlando, FL 32804
Conference Suite 182

Disclosures:

Florida Hospital's CPD Committee members have no financial relationships with any proprietary entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.

Dr. Melvin Field and Dr. Aamir Hussain have no financial relationships with any proprietary entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients.

Dr. Herbert B. Newton has financial relationships with the following companies: Genentech, Inc., Novocure, Tocagen, and Sigma Tau.

Certificate:

Participants must text the lecture code to receive the evaluation; the evaluation must be completed to receive both the certificate and credit with CE Broker.